The protective effect of M40401, a superoxide dismutase mimetic, on post-ischemic brain damage in Mongolian gerbils

BMC Pharmacology

Volumn 3, Issue , 2003, Pages

  Mollace, Vincenzo ^a   Iannone, Michelangelo ^b   Muscoli, Carolina ^a,c   Palma, Ernesto ^a   Granato, Teresa ^b   Modesti, Andrea ^d   Nisticò, Robert ^e   Rotiroti, Domenicantonio ^a   Salvemini, Daniela ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c MetaPhore Pharmaceuticals   (United States)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Antioxidants; Brain ischemia reperfusion; Electrocortical alterations; Oxidative stress

Indexed keywords

ANTIOXIDANT; M 40401; MALONALDEHYDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GERBIL; HIPPOCAMPUS; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; REPERFUSION INJURY;

EID: 0242605386     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-3-8     Document Type: Article

References (46)

1. Nehls DG, Park CK and McCulloch J: Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat J Cereb Blood Flow Metab 1989, 9:S376-S376.
2. Dirnagl U, Iadecola C and Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view Trends Neurosci 1999, 22:391-397.
3. Martin RL, Lloyd HG and Cowan AI: The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci 1994, 17:251-257.
4. Katsura K, Kristian T and Siesjo BK: Energy metabolism, ion homeostasis, and cell damage in the brain Biochem Soc Trans 1994, 22:991-996.
5. Furukawa K: The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons J Neurosci 1997, 17:8178-8186.
6. Chen ZL and Strickland S: Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin Cell 1997, 91:917-925.
7. Zhao Q, Pahlmark K, Smith ML and Siesjo BK: Delayed treatment with the spin trap alpha-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats Acta Physiol Scand 1994, 152:349-350.
8. Beckman JS, Beckman TW, Chen J, Marshall PA and Freeman BA: Apparent hydroxil radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide Proc Natl Acad Sci 1990, 87:1620-1624.
9. Beckman JS and Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 1996, 271:C1424-C1437.
10. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury Trends Neurosci 1997, 20:132-139.
11. Cerchiari EL, Hoel TM, Safar P and Sclarabassi RJ: Protective effects of combined superoxide dismutase and deferoxamine on recovery of cerebral blood flow and function after cardiac arrest in dogs Stroke 1987, 18:869-878.
12. Forsman M, Fleischer JE, Milde JH, Steen PA and Michenfelder JD: Superoxide dismutase and catalase failed to improve neurologic outcome after complite cerebral ischaemia in the dog Acta Anaesthesiol Scandin 1988, 32:152-155.
13. Cerchiari EL, Sclarabassi RJ, Safar P and Hoel TM: Effects of combined superoxide dismutase and deferoxamine on recovery of brainstem auditory evoked potentials and EEG after asphyxial cardiac arrest in dogs Resuscitation 1990, 19:25-40.
14. Tagaya M, Matsumoto M, Kitagawa K, Niinobe M, Ohtsuki T, Hata R, Ogawa S, Handa N, Mikoshiba K and Kamada T: Recombinant SOD can attenuate ischemic neuronal damage in gerbils Life Sci 1992, 51:253-259.
15. Freeman BA, Young SL and Crapo JD: Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury J Biol Chem 1983, 258:12534-12542.
16. Turrens JF, Crapo JD and Freeman BA: Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase J Clin Invest 1984, 73:87-95.
17. Beckman JS, Minor RL, White CW, Repine JE, Rosen GM and Freeman BA: Superoxide and catalase coniugated to polyethilene glycol increases endothelial enzyme activity and oxidant resistance J Biol Chem 1988, 263:6884-6892.
18. Baker K, Markus CB, Huffman K, Kruk H, Malfroy B and Doctrow SR: Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury J Pharmacol Exp Ther 1998, 284:215-21.
19. Salvemini D, Riley DP, Lennon PJ, Wang ZQ, Currie MC, Macarthur H and Misko TP: Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage Br J Pharmacol 1999, 126:304-306.
20. Salvemini D, Riley DP and Cuzzocrea S: SOD mimetics are coming of age Nature Reviews Drug Discovery 2002, 1:367-374.
21. Aston K, Rath N, Naik A, Slomczynska U, Schall OF and Riley DP: Computer-aided design (CAD) of Mn(II) complexes: superoxide dismutase mimetics with catalytic activity exceeding the native enzyme Inorg Chem 2001, 40:1779-1789.
22. Mollace V, Iannone M, Muscoli C, Palma E, Granato T, Rispoli V, Nistico' R, Rotiroti D and Salvemini D: The role of oxidative stress in paraquat-induced neurotoxicity in rats: protection by non peptidyl superoxide dismutase mimetic Neurosci Lett 2003, 335:163-6.
23. Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorski JA and Riley DP: A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats Science 1999, 286:304-306.
24. Riley DP, Lennon PJ, Neumann WL and Weiss RH: Toward the rational design of superoxide dismutase mimics: Mechanistic studies for the elucidation of substituent effects on the catalytic activity of macrocyclic manganese (II) complexes J Am Chem Soc 1997, 119:6522-6528.
25. Salvemini D and Riley DP: M40403-Superoxide dismutase mimetic Drugs Fut 2000, 25:1027-1033.
26. Linnik MD, Zobrist RH and Hatfield MD: Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats Stroke 1993, 24:2002-2009.
27. Bonfoco E, Krainic D, Ankarcrona M, Nicotera P and Lipton SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures Proc Natl Acad Sci 1995, 92:7162-7166.
28. Porcellati G, DeMedio GE, Fini C, Floridi A, Goracci G, Horrocks LA, Lazarewicz JW, Palmerini CA, Strosznajder J and Trovarelli J: Phospholipid and its metabolism in ischaemia Proc Eur Soc Neurochem 1978, 1:491-498.
29. Van Wylen DG, Park T, Rubio R and Berne RM: Increases in cerebral interstitial fluid adenosine concentration durino hypoxia, local potassium infusion, and ischaemia J Cereb Blood Flow Metab 1986, 6:522-528.
30. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo K, Thompson CB, Obrenovitch TP and Contreras TJ: Polymorphonuclear leukocyte accumulation in the brain regions with low blood flow during the early postischemic period Stroke 1986, 17:246-253.
31. Kochanek PM, Dutka AJ and Hallenbeck JM: Indomethacin, prostacyclin and heparin improve postischemic cerebral blood flow without affecting early postischemic granulocyte accumulation Stroke 1987, 18:634-637.
32. Spranger M, Krempien S, Schwab S, Donneberg S and Hacke W: Superoxide dismutase activity in serum of patients with acute cerebral ischaemic injury. Correlation with clinical course and infarct size Stroke 1997, 28:2425-2428.
33. Murakami K, Kondo T, Kawase M, Li Y, Sato S, Chen SF and Chan PH: Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency J Neurosci 1998, 18:205-213.
34. Toyoda T and Lee KS: Differential induction of superoxide dismutase in core and penumbra regions after transient focal ischaemia in the rat neocortex Neurosci Lett 1997, 235:29-32.
35. Sheng H, Brady TC, Pearlstein RD, Crapo JD and Warner DS: Extracellular superoxide ismutase deficiency worsens outcome from focal cerebral ischemia in the mouse Neurosci Lett 1999, 267:13-16.
36. Kawase M, Murakami K, Fujimura M, Morita-Fujimura Y, Gasche Y, Kondo T, Scott RW and Chan PH: Exacerbation of ischaemia in mutant mice with CuZn superoxide dismutase deficiency Stroke 1999, 30:1962-1968.
37. Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ and Chan PH: Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischaemia J Neurosci 1997, 17:4180-4189.
38. Bidmon HJ, Kato K, Schleicher A, Witte OW and Zilles K: Transient increase of manganese-superoxide dismutase in remote brain areas after focal photothrombotic cortical lesion Stroke 1998, 29:203-210.
39. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB and Mattson MP: Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxinitrate production, lipid peroxidation and mitochondrial dysfunction J Neurosci 1998, 18:687-697.
40. Sheng H, Bart RD, Oury TD, Pearlstein RD, Crapo JD and Warner DS: Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia Neuroscience 1999, 88:185-191.
41. Guegan C, Ceballos-Picot I, Chevalier E, Nicole A, Onteniente B and Sola B: Reduction of ischemic damage in NGF-transgenic mice: correlation with enhancement of antioxidant enzyme activities Neurobiol Dis 1999, 6:180-189.
42. Fujimura M, Morita-Fujimura Y, Narasimhan P, Copin JC, Kawase M and Chan PH: Copper-zinc superoxide dismutase prevents the early decrease of apurinic/apyrimidinic endonuclease and subsequent DNA fragmentation after transient focal cerebral ischemia in mice Stroke 1999, 30:2408-2415.
43. Wengenack TM, Curran GL and Poduslo JF: Post-ischemic, systemic administration of plyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia Brain Res 1997, 754:46-54.
44. Francis JW, Ren J, Warren L, Brown RHJr and Finklestein SP: Post-ischemic infusion of CuZn superoxide dismutase or SOD:Tet451 reduces cerebral infarction following focal ischemia/reperfusion in rats Exp Neurol 1997, 146:435-443.
45. Patel M and Day BJ: Metalloporphyrin class of therapeutic catalytic catalytic antioxidants Trends Pharmacol 1999, 20:359-364.
46. Ohkawa H, Ohishi H and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Analytical Biochem 1979, 95:351-358.